Production of microspheres

Details Production of microspheres Production of microspheres

2001-10-25

2008-05-20

Woodward, Michael (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

Reexamination Certificate

active

07374782

ABSTRACT:
Protein microspheres are produced by contacting an aqueous solution of a macromolecule and a polymer with a surface at a high surface area to volume ratio, and heating the solution. The microspheres are useful for preparing pharmaceuticals of defined dimensions which can be delivered to a patient by inhalation therapy.

REFERENCES:
patent: 3219533 (1965-11-01), Mullins
patent: 3737337 (1973-06-01), Schnoring et al.
patent: 3891570 (1975-06-01), Fukushima et al.
patent: 4083831 (1978-04-01), Santosusso
patent: 4389330 (1983-06-01), Tice et al.
patent: 4530840 (1985-07-01), Tice et al.
patent: 4612008 (1986-09-01), Wong et al.
patent: 4652441 (1987-03-01), Okada et al.
patent: 4728721 (1988-03-01), Yamamoto et al.
patent: 4744933 (1988-05-01), Rha et al.
patent: 4818542 (1989-04-01), DeLuca et al.
patent: 4849228 (1989-07-01), Yamamoto et al.
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 4904479 (1990-02-01), Illum
patent: 4917893 (1990-04-01), Okada et al.
patent: 4925677 (1990-05-01), Feijen
patent: 5008116 (1991-04-01), Cahn
patent: 5075109 (1991-12-01), Tice et al.
patent: 5102872 (1992-04-01), Singh et al.
patent: 5149543 (1992-09-01), Cohen et al.
patent: 5160745 (1992-11-01), DeLuca et al.
patent: 5204108 (1993-04-01), Illum
patent: 5213788 (1993-05-01), Ranney
patent: 5213812 (1993-05-01), Ruiz
patent: 5300464 (1994-04-01), Rittler
patent: 5330768 (1994-07-01), Park et al.
patent: 5360610 (1994-11-01), Tice et al.
patent: 5384133 (1995-01-01), Boyes et al.
patent: 5407609 (1995-04-01), Tice et al.
patent: 5417986 (1995-05-01), Reid et al.
patent: 5422120 (1995-06-01), Kim
patent: 5476663 (1995-12-01), Okada et al.
patent: 5480656 (1996-01-01), Okada et al.
patent: 5482927 (1996-01-01), Maniar et al.
patent: 5543158 (1996-08-01), Gref et al.
patent: 5556642 (1996-09-01), Kobayashi et al.
patent: 5573934 (1996-11-01), Hubbell et al.
patent: 5575987 (1996-11-01), Kamei et al.
patent: 5578709 (1996-11-01), Woiszwillo
patent: 5595760 (1997-01-01), Cherif-Cheikh
patent: 5599719 (1997-02-01), Woiszwillo
patent: 5603961 (1997-02-01), Suzuki et al.
patent: 5631020 (1997-05-01), Okada et al.
patent: 5631021 (1997-05-01), Okada et al.
patent: 5637309 (1997-06-01), Tajima et al.
patent: 5643607 (1997-07-01), Okada et al.
patent: 5650173 (1997-07-01), Ramstack et al.
patent: 5654008 (1997-08-01), Herbert et al.
patent: 5654010 (1997-08-01), Johnson et al.
patent: 5674521 (1997-10-01), Gehrke et al.
patent: 5851451 (1998-12-01), Takechi et al.
patent: 5932248 (1999-08-01), Chen et al.
patent: 5945126 (1999-08-01), Thanoo et al.
patent: 5981719 (1999-11-01), Woiszwillo et al.
patent: 5989463 (1999-11-01), Tracy et al.
patent: 6036976 (2000-03-01), Takechi et al.
patent: 6090925 (2000-07-01), Woiszwillo
patent: 6120787 (2000-09-01), Gustafsson et al.
patent: 6153211 (2000-11-01), Hubbell et al.
patent: 6265389 (2001-07-01), Burke
patent: 6268053 (2001-07-01), Woiszwillo et al.
patent: 6270795 (2001-08-01), Jones et al.
patent: 6270802 (2001-08-01), Thanoo et al.
patent: 6361798 (2002-03-01), Thanoo et al.
patent: 6395253 (2002-05-01), Levy et al.
patent: 6395300 (2002-05-01), Straub et al.
patent: 6395302 (2002-05-01), Hennink et al.
patent: 6455074 (2002-09-01), Tracy et al.
patent: 6458387 (2002-10-01), Scott et al.
patent: 6475468 (2002-11-01), Zhu et al.
patent: 6475995 (2002-11-01), Roy et al.
patent: 6506410 (2003-01-01), Park et al.
patent: 6596316 (2003-07-01), Lyons et al.
patent: 6749866 (2004-06-01), Bernstein et al.
patent: 6814980 (2004-11-01), Levy et al.
patent: 6830737 (2004-12-01), Ramstack
patent: 6861064 (2005-03-01), Laakso et al.
patent: 2001/0002261 (2001-05-01), Morrison et al.
patent: 2001/0007853 (2001-07-01), Dimarchi et al.
patent: 2002/0146459 (2002-10-01), Levy et al.
patent: 2003/0007990 (2003-01-01), Blankenship et al.
patent: 2003/0059474 (2003-03-01), Scott et al.
patent: 2003/0064033 (2003-04-01), Brown et al.
patent: 2004/0014698 (2004-01-01), Hortelano et al.
patent: 2004/0043076 (2004-03-01), Dulieu et al.
patent: 2004/0091541 (2004-05-01), Unger
patent: 2005/0048127 (2005-03-01), Brown et al.
patent: 2005/0147687 (2005-07-01), Rashba-Step et al.
patent: 2157793 (1994-09-01), None
patent: 0 248 531 (1987-12-01), None
patent: 0 351 296 (1990-01-01), None
patent: 0 357 401 (1990-03-01), None
patent: 0 809 110 (1997-11-01), None
patent: 1 060 741 (2000-12-01), None
patent: 08-225454 (1996-09-01), None
patent: WO 93/11743 (1993-06-01), None
patent: WO 93/11744 (1993-06-01), None
patent: WO 93/11745 (1993-06-01), None
patent: WO 94/07514 (1994-04-01), None
patent: WO 94/18947 (1994-09-01), None
patent: WO 94/20856 (1994-09-01), None
patent: WO 96/19197 (1996-06-01), None
patent: WO 99/48479 (1999-09-01), None
patent: WO 00/00215 (2000-01-01), None
patent: WO 01/05379 (2001-01-01), None
patent: WO 01/28524 (2001-04-01), None
patent: WO 02/43580 (2002-06-01), None
patent: WO 03/015750 (2003-02-01), None
US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn)
Arshady et al., “Preperationof poly nano- and microspheres by vinyl polymerization techinques,” J. Microencapsulation, 1988, vol. 5, No. 2, 101-114.
Sefton et al., “Ethylene-Vinyl Acetate Copolymer Microspheres for Controlled Release of Macromolecules,” 1984, J. Pharamaceutical Sciences, vol. 73, No. 12, 1859-1861.
Adjei et al., Bioavailability of Leuprolide Acetate Following Nasal and Inhalation Delivery to Rats and Healthy Humans,Pharm. Res., vol. 9, No. 2, pp. 244-249 (1992).
Ahn et al., Biodegradable poly(ethylenimine) for plasmid DNA delivery,Journal of Controlled Release, (2002), vol. 80 (1-3), pp. 273-282.
Arshady, Preperation of polymer nano- and microspheres by vinyl polymerization techniques,J. Microencapsulation, (1988), vol. 5, No. 2, pp. 101-114.
Banchereau et al., Dendritic cells and the control of immunity,Nature, (1998), vol. 392, pp. 245-252.
Berton et al., Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular BioVector (SMBV),Biochimica Biophysica Acta, (1997), vol. 1355, pp. 7-19.
Bisker-Leib et al., Uniform Microsphere Formation from Small Organic Molecules, Transac. of the 31st Control.Rel. Soc. Annual Meeting, (2004), #631A.
Bisker-Leib et al., Anti-Factor VII Monoclonal Antibody Microspheres, in Proceed. of the 2004-Amer. Assoc. of Pharm. Scs Natl. Biotech. Conference, (2004), p. 76.
Boussif et al., A versatile vector for gene and oligonucleotide transfer into cells in culture andin vivo: Polyethylenimine,Proc. Natl. Acad. Sci.(U.S.A)., (1995), vol. 92, pp. 7297-7301.
Brazeau et al.,In vitromyotoxicity of selected cationic macromolecules used in non-viral gene delivery,Pharmaceutical Research, (1998), vol. 15(5), pp. 680-684.
Brown et al., Pulmonary Delivery of Novel Insulin Microspheres,Proceed, Respiratory Drug Delivery VIII, (2002), pp. 431-434.
Brown et al., PROMAXX Microsphere Characterization,Proceed, Respiratory Drug Delivery LX, (2004), pp. 477-479.
Brown et al., Tetrafluoroethane (HFC 134A) Propellant-Drive Aerosols of Proteins,Pharm. Res., 14(11): 1542-1547, (1997).
Brown et al. Propellant-Driven Aerosols for Delivery of Proteins in the Respiratory Tract,J. Aerosol Med., vol. 8, No. 1 43-58 (1995).
Brown et al., Propellant-driven Aerosols of Functional Proteins as Potential Therapeutic Agents in the Respiratory Tract,Immunopharmacology, vol. 28, 241-257 (1994).
Bustami et al., Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide,Pharmaceutical Research, (2000), vol. 17, No. 11, pp. 1360-1366.
Byrne et al., Dendritic cells: making progress with tumour regression?Immunology and Cell Biology, (2002), vol. 80, pp. 520-530.
Chamarthy et al., A cationic peptide consists of ornithine and histidine repeats augments gene transfer in dendritic cells,Molecular Immunology, (2003), vol. 40(8), pp. 483-490.
Chollet et al, Side-effects of a systemic injection of linear polyethylenimine-DNA complexes,Journal of Gene Medicine, (2002), vol. 4, pp. 84-91.
Chu et al., Efficiency of cytoplasmic delivery by pH-sensitive liposomes

Affiliated with

Also associated with

Rating

Production of microspheres does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of microspheres, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of microspheres will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3984730